Congenital melanocytic nevi: Where are we now?: Part II. Treatment options and approach to treatment

Omar A. Ibrahimi, Ali Alikhan, Daniel B Eisen

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.

Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
Volume67
Issue number4
DOIs
StatePublished - Oct 2012

    Fingerprint

Keywords

  • CMN
  • congenital melanocytic nevi
  • Er:YAG
  • erbium:yttrium-aluminum-garnet
  • GCMN
  • giant congenital melanocytic nevi
  • malignant melanoma
  • MM
  • Nd:YAG
  • neodymium-doped yttrium aluminum garnet
  • NMRL
  • normal-mode ruby laser
  • PAS
  • projected adult size
  • Q-switched ruby laser
  • QSRL

ASJC Scopus subject areas

  • Dermatology

Cite this